FCPA Compliance Strategies for Medical Device & Pharma Companies

The Foreign Corrupt Practices Act (FCPA) has had a major impact on the way companies conduct business abroad. A U.S. anti-corruption law jointly enforced by the Department of Justice and the Securities and Exchange Commission, its main provisions deal with improper payments to foreign officials and questionable accounting practices used to hide them. Violating the FCPA can result in both criminal and civil penalties, and the requirements are complex, applying to both companies in the U.S. and foreign-based companies subject to U.S. securities laws. Past enforcement actions have crossed industry boundaries and included the pharmaceutical industry. Lately, there has been an increase in FCPA enforcement activity in the medical device industry as well.

In this audio conference, our speakers combine their experience with real-world case studies to provide a clear background on the FCPA requirements and enforcement trends, along with practical compliance strategies to keep device and pharma companies from running afoul of the law.

FCPA Compliance Strategies for Medical Device & Pharma Companies is being presented by Bethany Hills & Michelle Merola, with Hodgson Russ LLP and airs Wednesday, April 1, 2009. For more details or to register for this event, please visit our site www.fxconferences.com

Pharma 2010: The Threshold of Innovation

While some analysts predict the pharmaceutical industry will grow by 9% by the year 2010, IBM Business Consulting Services is anticipating a much lower rate of 5.3%. However, in Pharma 2010: The Threshold of Innovation, IBM predicts that a new business model based on Targeted Treatment Solutions has the potential to achieve breakthrough growth. The authors propose that this new business model is needed to meet the challenge of governments and insurers who are no longer willing or able to pay high prices for "me too" medicines.

This presentation provides an in-depth overview of the "Pharma 2010" strategies that will lead to a more adaptive and flexible way of conducting business and treating patients.

Pharma 2010: The Threshold of Innovation was presented by Sam Barnett, Lead Partner, Life Sciences & Pharma of IBM Business Consulting Services and aired on 2004-06-29 and is available for download at www.fxconferences.com